The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications
Open Access
- 15 November 1996
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 127 (1), 1-11
- https://doi.org/10.1016/s0021-9150(96)05953-9
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosisAmerican Heart Journal, 1995
- Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbitsLife Sciences, 1994
- Termination of endothelin signaling: Role of nitric oxideJournal of Cellular Physiology, 1994
- Role of superoxide anions in the mediation of endothelium-dependent contractions.Hypertension, 1994
- L-Arginine Inhibits Balloon Catheter-Induced Intimal HyperplasiaBiochemical and Biophysical Research Communications, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Effects of L-arginine on forearm vessels and responses to acetylcholine.Hypertension, 1992
- Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat.Hypertension, 1990
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980